Diversified Trust Co Sells 2,055 Shares of Cigna Group $CI

Diversified Trust Co trimmed its holdings in shares of Cigna Group (NYSE:CI) by 36.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,639 shares of the health services provider’s stock after selling 2,055 shares during the quarter. Diversified Trust Co’s holdings in Cigna Group were worth $971,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in shares of Cigna Group by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock valued at $7,203,754,000 after acquiring an additional 414,834 shares during the last quarter. State Street Corp raised its holdings in Cigna Group by 1.8% in the 4th quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock worth $3,396,132,000 after acquiring an additional 224,122 shares during the period. Massachusetts Financial Services Co. MA lifted its position in Cigna Group by 8.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after acquiring an additional 903,334 shares during the last quarter. Dodge & Cox lifted its position in Cigna Group by 19.7% during the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after acquiring an additional 1,833,389 shares during the last quarter. Finally, Sanders Capital LLC boosted its holdings in Cigna Group by 0.5% during the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock valued at $2,256,469,000 after acquiring an additional 35,150 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Performance

NYSE:CI opened at $283.20 on Wednesday. The firm has a market capitalization of $74.91 billion, a PE ratio of 12.01, a price-to-earnings-growth ratio of 1.09 and a beta of 0.28. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a 12-month low of $239.51 and a 12-month high of $338.89. The firm has a 50-day moving average price of $284.10 and a 200 day moving average price of $278.51.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. During the same period in the previous year, the business earned $6.74 earnings per share. The company’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Research analysts anticipate that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were paid a $1.56 dividend. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s payout ratio is currently 26.45%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on CI. Deutsche Bank Aktiengesellschaft lowered Cigna Group from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $303.00 to $302.00 in a research note on Wednesday, May 20th. Robert W. Baird set a $337.00 target price on Cigna Group in a research note on Friday, May 1st. Barclays lowered Cigna Group from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $310.00 to $304.00 in a report on Tuesday, May 26th. Raymond James Financial set a $340.00 price target on Cigna Group in a report on Friday, May 1st. Finally, Guggenheim increased their price objective on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a research report on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $338.30.

Insiders Place Their Bets

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.